Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B.
Boyd RS, Adam PJ, Patel S, Loader JA, Berry J, Redpath NT, Poyser HR, Fletcher GC, Burgess NA, Stamps AC, Hudson L, Smith P, Griffiths M, Willis TG, Karran EL, Oscier DG, Catovsky D, Terrett JA, Dyer MJ. Boyd RS, et al. Among authors: oscier dg. Leukemia. 2003 Aug;17(8):1605-12. doi: 10.1038/sj.leu.2402993. Leukemia. 2003. PMID: 12886250
Cellular/cytogenetic events in CLL.
Catovsky D, Oscier DG, Einhorn S, Garcia-Marco JA. Catovsky D, et al. Among authors: oscier dg. Leuk Lymphoma. 1996 Oct;22 Suppl 2:41-5. doi: 10.3109/10428199609102701. Leuk Lymphoma. 1996. PMID: 9021707 Review. No abstract available.
Male preponderance in chronic lymphocytic leukemia utilizing IGHV 1-69.
Walewska R, Majid A, Davis Z, Dusanjh P, Kennedy DB, Oscier DG, Dyer MJ. Walewska R, et al. Among authors: oscier dg. Leukemia. 2007 Dec;21(12):2537-8. doi: 10.1038/sj.leu.2404836. Epub 2007 Jun 28. Leukemia. 2007. PMID: 17597803 No abstract available.
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.
Larrayoz M, Rose-Zerilli MJ, Kadalayil L, Parker H, Blakemore S, Forster J, Davis Z, Steele AJ, Collins A, Else M, Catovsky D, Oscier DG, Strefford JC. Larrayoz M, et al. Among authors: oscier dg. Leukemia. 2017 Feb;31(2):510-514. doi: 10.1038/leu.2016.298. Epub 2016 Oct 26. Leukemia. 2017. PMID: 27773930 Free PMC article. Clinical Trial. No abstract available.
CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Majid A, Lin TT, Best G, Fishlock K, Hewamana S, Pratt G, Yallop D, Buggins AG, Wagner S, Kennedy BJ, Miall F, Hills R, Devereux S, Oscier DG, Dyer MJ, Fegan C, Pepper C. Majid A, et al. Among authors: oscier dg. Leuk Res. 2011 Jun;35(6):750-6. doi: 10.1016/j.leukres.2010.10.022. Epub 2010 Nov 18. Leuk Res. 2011. PMID: 21093051
253 results